Reaction Details Report a problem with these data
Target
Interleukin-6
Ligand
BDBM419194
Substrate
n/a
Meas. Tech.
Interleukin 6 Induction Assay
EC50
4.90±n/a nM
Citation
 Young, IS; Gangwar, S; Posy, SL; Poudel, YB; Sivaprakasam, P Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor US Patent  US10457681 Publication Date 10/29/2019 
Target
Name:
Interleukin-6
Synonyms:
B-cell stimulatory factor 2 | BSF-2 | CDF | CTL differentiation factor | Hybridoma growth factor | IFN-beta-2 | IFNB2 | IL-6 | IL6 | IL6_HUMAN | Interferon beta-2
Type:
n/a
Mol. Mass.:
23717.96
Organism:
Homo sapiens (Human)
Description:
P05231
Residue:
212
Sequence:
MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM
  
Inhibitor
Name:
BDBM419194
Synonyms:
US10457681, Compound Ia-02 | US10487084, Compound Ia-02 | US10981914, Compound Ia-02
Type:
Small organic molecule
Emp. Form.:
C27H33N7O2S
Mol. Mass.:
519.662
SMILES:
CCCCOc1nc(N)c2nc(O)n(Cc3ccc4N(C)c5ccc(CNC(C)C)cc5Sc4c3)c2n1
Structure:
Search PDB for entries with ligand similarity: